Mild-to-moderate Psoriasis Vulgaris
1 clinical trials · Condition
◉ Watch Mild-to-moderate Psoriasis Vulgaris
| Record | Firm | Date |
|---|---|---|
| Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris (NCT01595997) | Delenex Therapeutics AG | 2012-02-01 |
Track Mild-to-moderate Psoriasis Vulgaris automatically
Every clearance here is in the API, with alerts when new ones post.